Reye’s syndrome is a rare but serious condition that causes sudden swelling in the brain and fat buildup in the liver, primarily affecting children and teenagers recovering from a viral illness. It is strongly linked to the use of aspirin during infections like the flu or chickenpox. Once relatively common, the condition has become extremely rare since public health warnings in the 1980s discouraged giving aspirin to young people.
The Aspirin Connection
The link between aspirin and Reye’s syndrome was established through multiple epidemiologic studies in the early 1980s. In 1982, the U.S. Surgeon General issued a formal advisory warning parents and healthcare providers against using aspirin or any salicylate-containing medication in children with influenza or chickenpox. The evidence was strong enough that it changed medical practice worldwide.
The core problem involves damage to the energy-producing structures inside cells, particularly in the liver and brain. When aspirin is taken during certain viral infections, it appears to trigger a cascade of metabolic failure. The liver loses its ability to process toxins normally, ammonia builds up in the blood, and the brain begins to swell. This combination can progress from mild confusion to life-threatening coma within days.
Not every case is tied to aspirin, and researchers still don’t fully understand why some children are vulnerable while others aren’t. But the association was consistent and compelling enough to reshape how we treat fevers in children. In the U.S., the FDA recommends that aspirin not be given to anyone under 19 during episodes of fever. In the UK, the cutoff is 16 years of age unless a doctor specifically advises it.
Who Is at Risk
Reye’s syndrome most commonly strikes children between the ages of 4 and 14, though it can occur at any age. The typical scenario involves a child who is recovering from a viral illness, particularly influenza or chickenpox, and who has been given aspirin or a product containing salicylates to manage fever or pain. The syndrome usually appears as the child seems to be getting better from the initial infection, not during its peak.
One reason parents sometimes unknowingly give their children salicylates is that aspirin isn’t always labeled as “aspirin.” It can appear in over-the-counter cold remedies, anti-nausea medications, and even some topical products under names like acetylsalicylic acid or salicylate. Reading ingredient labels carefully matters, especially during flu season or when a child has a rash-causing illness.
How Symptoms Progress
Reye’s syndrome follows a recognized pattern of worsening stages, and early recognition is critical. The CDC describes five distinct stages of clinical progression.
In the earliest stage, a child who seemed to be recovering from a virus begins vomiting persistently. This isn’t a single episode of nausea; it’s heavy, repeated vomiting that doesn’t stop. At the same time, the child becomes unusually sleepy or lethargic, may have nightmares, and seems confused. Many parents initially mistake this for a worsening of the original illness.
If the condition advances to stage two, the child becomes disoriented, agitated, or combative. Breathing may become rapid, and the heart rate increases. By stage three, the child slips into a coma-like state and stops responding meaningfully to the world around them. Stages four and five involve deepening coma, seizures, loss of reflexes, and ultimately respiratory failure. Without intervention, stage five is fatal.
The speed of this progression varies. Some children move through these stages over several days, while others deteriorate within hours. The earlier the syndrome is caught and treated, the better the outcome.
How It’s Diagnosed
There is no single test that confirms Reye’s syndrome. Diagnosis relies on a combination of clinical symptoms and blood work. The hallmark findings are a threefold or greater spike in liver enzymes and elevated blood ammonia levels in a child with unexplained brain swelling following a viral illness. A liver biopsy, which shows a characteristic pattern of fat deposits in liver cells, can confirm the diagnosis but isn’t always performed.
One important diagnostic challenge is distinguishing true Reye’s syndrome from “Reye-like syndrome,” a term for conditions that produce nearly identical symptoms but stem from inherited metabolic disorders. The most notable of these is a deficiency in the body’s ability to break down certain fats for energy. As genetic testing has improved since the 1990s, doctors have identified more children whose apparent Reye’s syndrome actually resulted from an undiagnosed inborn metabolic condition. The end result of both is similar: the cell’s energy machinery fails, the liver and brain suffer, and the child becomes critically ill. But the underlying cause, and therefore the long-term management, differs significantly.
What Treatment Looks Like
There is no cure for Reye’s syndrome. Treatment focuses entirely on supporting the body while the damage runs its course, with the primary goal of reducing brain swelling and preventing permanent injury. Children with Reye’s syndrome are treated in intensive care.
The medical team works to control intracranial pressure, stabilize blood sugar (which often drops dangerously low), correct the buildup of ammonia, and support liver function. How aggressive the treatment needs to be depends on what stage the child has reached by the time they arrive at the hospital. A child caught in stage one has a far better chance of full recovery than one who has progressed to stage three or beyond.
Outcomes correlate directly with how early the syndrome is identified. Children diagnosed and treated in the first stage typically recover fully, though the process can still take weeks. Those who reach the later stages face significant risks of lasting neurological damage, including problems with memory, attention, and motor coordination. The historical mortality rate for Reye’s syndrome was once above 40%, but earlier recognition and improved intensive care have brought that number down considerably.
Why It’s Now Extremely Rare
Reye’s syndrome is one of the clearest public health success stories tied to a single intervention. At its peak in the early 1980s, the U.S. reported several hundred cases per year. After the Surgeon General’s advisory and subsequent warning labels on aspirin products, case numbers plummeted. Today, fewer than two cases per year are reported in the United States. The UK saw a similar decline after implementing its own warnings.
This dramatic drop is the reason most parents today have only vaguely heard of Reye’s syndrome, if they’ve heard of it at all. The widespread switch to acetaminophen and ibuprofen as the default fever reducers for children effectively removed the primary trigger from most households. But the condition hasn’t been eliminated entirely, which is why the aspirin warning for young people remains in place and why pediatricians still flag it as a concern during flu season.